Mechanical Dyssynchrony Combined with Septal Scarring Reliably Identifies Responders to Cardiac Resynchronization Therapy.

Autor:	Duchenne J; Department of Cardiovascular Sciences, KU Leuven, 3000 Leuven, Belgium.; Department of Cardiovascular Diseases, University Hospitals Leuven, 3000 Leuven, Belgium., Larsen CK; Institute for Surgical Research, Oslo University Hospital and University of Oslo, 0450 Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, 0313 Oslo, Norway.; Department of Cardiology, Oslo University Hospital, 0379 Oslo, Norway., Cvijic M; Department of Cardiovascular Sciences, KU Leuven, 3000 Leuven, Belgium.; Department of Cardiovascular Diseases, University Hospitals Leuven, 3000 Leuven, Belgium., Galli E; Inserm, LTSI-UMR, 1099, 35042 Rennes, France.; Department of Cardiology, CHU Rennes, 35033 Rennes, France., Aalen JM; Institute for Surgical Research, Oslo University Hospital and University of Oslo, 0450 Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, 0313 Oslo, Norway.; Department of Cardiology, Oslo University Hospital, 0379 Oslo, Norway., Klop B; Department of Cardiovascular Sciences, KU Leuven, 3000 Leuven, Belgium.; Department of Cardiovascular Diseases, University Hospitals Leuven, 3000 Leuven, Belgium., Mirea O; Department of Cardiovascular Sciences, KU Leuven, 3000 Leuven, Belgium.; Department of Cardiovascular Diseases, University Hospitals Leuven, 3000 Leuven, Belgium.; Department of Cardiology, University of Medicine and Pharmacy, 200349 Craiova, Romania., Puvrez A; Department of Cardiovascular Sciences, KU Leuven, 3000 Leuven, Belgium.; Department of Cardiovascular Diseases, University Hospitals Leuven, 3000 Leuven, Belgium., Bézy S; Department of Cardiovascular Sciences, KU Leuven, 3000 Leuven, Belgium.; Department of Cardiovascular Diseases, University Hospitals Leuven, 3000 Leuven, Belgium., Wouters L; Department of Cardiovascular Sciences, KU Leuven, 3000 Leuven, Belgium.; Department of Cardiovascular Diseases, University Hospitals Leuven, 3000 Leuven, Belgium., Minten L; Department of Cardiovascular Sciences, KU Leuven, 3000 Leuven, Belgium.; Department of Cardiovascular Diseases, University Hospitals Leuven, 3000 Leuven, Belgium., Sirnes PA; Institute for Surgical Research, Oslo University Hospital and University of Oslo, 0450 Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, 0313 Oslo, Norway.; Department of Cardiology, Oslo University Hospital, 0379 Oslo, Norway., Khan FH; Institute for Surgical Research, Oslo University Hospital and University of Oslo, 0450 Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, 0313 Oslo, Norway.; Department of Cardiology, Oslo University Hospital, 0379 Oslo, Norway., Voros G; Department of Cardiovascular Sciences, KU Leuven, 3000 Leuven, Belgium.; Department of Cardiovascular Diseases, University Hospitals Leuven, 3000 Leuven, Belgium., Willems R; Department of Cardiovascular Sciences, KU Leuven, 3000 Leuven, Belgium.; Department of Cardiovascular Diseases, University Hospitals Leuven, 3000 Leuven, Belgium., Penicka M; Cardiovascular Center Aalst, OLV Clinic, 9300 Aalst, Belgium., Kongsgård E; Institute for Surgical Research, Oslo University Hospital and University of Oslo, 0450 Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, 0313 Oslo, Norway.; Department of Cardiology, Oslo University Hospital, 0379 Oslo, Norway., Hopp E; Division of Radiology and Nuclear Medicine, Oslo University Hospital, 0379 Oslo, Norway., Bogaert J; Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium.; Department of Radiology, University Hospitals Leuven, 3000 Leuven, Belgium., Smiseth OA; Institute for Surgical Research, Oslo University Hospital and University of Oslo, 0450 Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, 0313 Oslo, Norway.; Department of Cardiology, Oslo University Hospital, 0379 Oslo, Norway., Donal E; Inserm, LTSI-UMR, 1099, 35042 Rennes, France.; Department of Cardiology, CHU Rennes, 35033 Rennes, France., Voigt JU; Department of Cardiovascular Sciences, KU Leuven, 3000 Leuven, Belgium.; Department of Cardiovascular Diseases, University Hospitals Leuven, 3000 Leuven, Belgium.
Jazyk:	angličtina
Zdroj:	Journal of clinical medicine [J Clin Med] 2023 Sep 21; Vol. 12 (18). Date of Electronic Publication: 2023 Sep 21.
DOI:	10.3390/jcm12186108
Abstrakt:	Background and aim: The presence of mechanical dyssynchrony on echocardiography is associated with reverse remodelling and decreased mortality after cardiac resynchronization therapy (CRT). Contrarily, myocardial scar reduces the effect of CRT. This study investigated how well a combined assessment of different markers of mechanical dyssynchrony and scarring identifies CRT responders. Methods: In a prospective multicentre study of 170 CRT recipients, septal flash (SF), apical rocking (ApRock), systolic stretch index (SSI), and lateral-to-septal (LW-S) work differences were assessed using echocardiography. Myocardial scarring was quantified using cardiac magnetic resonance imaging (CMR) or excluded based on a coronary angiogram and clinical history. The primary endpoint was a CRT response, defined as a ≥15% reduction in LV end-systolic volume 12 months after implantation. The secondary endpoint was time-to-death. Results: The combined assessment of mechanical dyssynchrony and septal scarring showed AUCs ranging between 0.81 (95%CI: 0.74-0.88) and 0.86 (95%CI: 0.79-0.91) for predicting a CRT response, without significant differences between the markers, but significantly higher than mechanical dyssynchrony alone. QRS morphology, QRS duration, and LV ejection fraction were not superior in their prediction. Predictive power was similar in the subgroups of patients with ischemic cardiomyopathy. The combined assessments significantly predicted all-cause mortality at 44 ± 13 months after CRT with a hazard ratio ranging from 0.28 (95%CI: 0.12-0.67) to 0.20 (95%CI: 0.08-0.49). Conclusions: The combined assessment of mechanical dyssynchrony and septal scarring identified CRT responders with high predictive power. Both visual and quantitative markers were highly feasible and demonstrated similar results. This work demonstrates the value of imaging LV mechanics and scarring in CRT candidates, which can already be achieved in a clinical routine.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.